1. Home
  2. QRTEB vs PHVS Comparison

QRTEB vs PHVS Comparison

Compare QRTEB & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRTEB
  • PHVS
  • Stock Information
  • Founded
  • QRTEB 1991
  • PHVS 2015
  • Country
  • QRTEB United States
  • PHVS Netherlands
  • Employees
  • QRTEB N/A
  • PHVS N/A
  • Industry
  • QRTEB Catalog/Specialty Distribution
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • QRTEB Consumer Discretionary
  • PHVS Health Care
  • Exchange
  • QRTEB Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • QRTEB 865.4M
  • PHVS 894.8M
  • IPO Year
  • QRTEB N/A
  • PHVS 2021
  • Fundamental
  • Price
  • QRTEB $2.00
  • PHVS $16.49
  • Analyst Decision
  • QRTEB
  • PHVS Strong Buy
  • Analyst Count
  • QRTEB 0
  • PHVS 5
  • Target Price
  • QRTEB N/A
  • PHVS $41.60
  • AVG Volume (30 Days)
  • QRTEB 3.4K
  • PHVS 35.8K
  • Earning Date
  • QRTEB 02-27-2025
  • PHVS 04-09-2025
  • Dividend Yield
  • QRTEB N/A
  • PHVS N/A
  • EPS Growth
  • QRTEB N/A
  • PHVS N/A
  • EPS
  • QRTEB N/A
  • PHVS N/A
  • Revenue
  • QRTEB $10,236,000,000.00
  • PHVS N/A
  • Revenue This Year
  • QRTEB N/A
  • PHVS N/A
  • Revenue Next Year
  • QRTEB N/A
  • PHVS N/A
  • P/E Ratio
  • QRTEB N/A
  • PHVS N/A
  • Revenue Growth
  • QRTEB N/A
  • PHVS N/A
  • 52 Week Low
  • QRTEB $2.00
  • PHVS $15.21
  • 52 Week High
  • QRTEB $6.30
  • PHVS $28.17
  • Technical
  • Relative Strength Index (RSI)
  • QRTEB 39.04
  • PHVS 36.48
  • Support Level
  • QRTEB $2.01
  • PHVS $17.01
  • Resistance Level
  • QRTEB $2.45
  • PHVS $17.94
  • Average True Range (ATR)
  • QRTEB 0.19
  • PHVS 0.71
  • MACD
  • QRTEB 0.01
  • PHVS -0.09
  • Stochastic Oscillator
  • QRTEB 0.00
  • PHVS 17.44

About QRTEB Qurate Retail Inc. Series B

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: